World Lifestyle Archives | Be Korea-savvy

Archive by category World Lifestyle

Accelerate Diagnostics Announces Sizeable Release of New Data at ECCMID 2018

Accelerate Diagnostics Announces Sizeable Release of New Data at ECCMID 2018

TUCSON, Ariz., Apr. 21 (Korea Bizwire) — Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2018, located in IFEMA – Feria de Madrid, Madrid, Spain, April 21 – 24th. The symposium presentations on Monday, [...]

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

RENSSELAER, N.Y., Apr. 20 (Korea Bizwire) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). [...]

sky100 Hong Kong Observation Deck Celebrates its 7th Anniversary with Offers for All Visitors

sky100 Hong Kong Observation Deck Celebrates its 7th Anniversary with Offers for All Visitors

HONG KONG, CHINA, Apr. 20 (Korea Bizwire) - Located on the 100th floor of International Commerce Centre, the tallest building in Hong Kong, sky100 Hong Kong Observation Deck (sky100) is Hong Kong’s only indoor observation deck offering 360-degree panoramic views of the city and its famous Victoria Harbour.  With the opening of Café 100 by The Ritz-Carlton, Hong Kong, sky100 is now world’s first observation [...]

SpeeDx Receives FDA Clearance for Mycoplasma Genitalium Product

SpeeDx Receives FDA Clearance for Mycoplasma Genitalium Product

SYDNEY, Australia, Apr. 19 (Korea Bizwire) — SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company’s recently incorporated US entity, SpeeDx Inc. The announcement coincides with the FDA registration of the Australian parent company – SpeeDx Pty [...]

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

RENSSELAER, N.Y., Apr. 19 (Korea Bizwire) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models.  As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis [...]

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

CAMBRIDGE, United Kingdom, Apr. 16 (Korea Bizwire) — AstraZeneca and MedImmune, its global biologics research and development arm, today presented efficacy and safety data from two Phase I trials evaluating Imfinzi (durvalumab) in combination with tremelimumab in 2nd-line immunotherapy-naïve patients with either non-squamous advanced non-small cell lung cancer (NSCLC) (Study 006) or metastatic urothelial carcinoma [...]

Graduate Management Admission Council Acquires UK-Based Online Publishing Company BusinessBecause

Graduate Management Admission Council Acquires UK-Based Online Publishing Company BusinessBecause

RESTON, Va., Apr. 12 (Korea Bizwire) — The Graduate Management Admission Council (GMAC), a nonprofit association of leading global business schools, has acquired the UK-based online publishing company BusinessBecause. Consistent with its mission, GMAC is actively committed to providing new solutions that help candidates and schools discover, evaluate, and connect with each other. It’s estimated [...]

Neuralstem to Present Clinical Update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day

Neuralstem to Present Clinical Update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day

GERMANTOWN, Md., Apr. 11 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, Chief Scientific Officer of Neuralstem, will be providing a clinical update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day at the Metropolitan Club in [...]

OmniComm Systems Signs First TrialMaster® Customer in China

OmniComm Systems Signs First TrialMaster® Customer in China

FORT LAUDERDALE, Fla., Apr. 10 (Korea Bizwire) — Shanghai HEP Pharma Co. LTD, a research and development company focused on developing innovative drugs for hepatitis B, has signed a new agreement with OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology. Under the agreement, Shanghai HEP Pharma will use OmniComm’s TrialMaster [...]

Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury

Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury

GERMANTOWN, Md., Apr. 10 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced that it completed the first surgery in the second, cervical injury cohort of a Phase 1 clinical trial in patients with chronic spinal cord injury [...]